Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SYMBICORT controller with SABA versus anti-inflammatory reliever in asthma
2018-003467-64Phase 4Unknown
- Sponsor
- AstraZeneca
- Start
- Nov 2018
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of budesonide and salbutamol in asthma (2 arms), sponsored by AstraZeneca. Primary endpoint: Daily individual profiles over 24 weeks. Status: unknown.
02
Drugs
budesonidesalbutamol
03
Conditions
asthma
Beyond the preview
Go deeper on 2018-003467-64.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-003467-64.